Suneel Gupta - 19 Oct 2023 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Chief Development Officer
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Suneel Gupta
Issuer symbol
PTGX
Transactions as of
19 Oct 2023
Net transactions value
+$147,600
Form type
4
Filing time
23 Oct 2023, 16:31:12 UTC
Previous filing
02 Jun 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Options Exercise $147,600 +20,000 +13% $7.38 168,317 19 Oct 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTGX Stock Option (right to buy) Options Exercise $0 -20,000 -29% $0.000000 50,000 19 Oct 2023 Common Stock 20,000 $7.38 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes an aggregate of 280 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2023.
F2 These stock options are fully vested.